The role of calcitriol in the treatment of osteoporosis

Calcified Tissue International

Volumn 66, Issue 3, 2000, Pages 239-240

  Nuti, R ^a   Bonucci, E ^b   Brancaccio, D ^c   Gallagher, J C ^d   Gennari, C ^a   Mazzuoli, G ^b   Passeri, M ^e   Sambrook, P ^f  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN PAOLO HOSPITAL   (Italy)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PARMA   (Italy)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; ESTROGEN; PARATHYROID HORMONE; VITAMIN D;

AGED; BONE DENSITY; BONE MINERAL; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; HUMAN; INTESTINE ABSORPTION; NOTE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; VITAMIN D METABOLISM;

EID: 0033983727     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005840     Document Type: Note

References (32)

1. Reichel H, Koeffler PH, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991
2. Holick MF (1995) Vitamin D: photobiology, metabolism, and clinical applications. In: DeGroot L, Besser H, Burger HG et al. (eds) Endocrinology, 3rd ed. WB Saunders, Philadelphia, pp 990-1013
3. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW (1998) The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349
4. Norman AW (1998) Receptors for 1,25(OH)2D3: past, present, and future. J Bone Miner Res 13:1360-1369
5. Caniggia A, Nuti R, Loré F, Vattimo A (1984) The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis. J Endocrinol Invest 7:373-378
6. Nordin CBE, Morris HA (1992) Osteoporosis and vitamin D. J Cell Biochem 49:19-25
7. DeLuca HF (1997) 1,25-Dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis. Osteoporosis Int 7(Suppl 3):S24-S29
8. Gallagher JC, Riggs BL, Eisman J, DeLuca HF (1979) Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest 64:729-736
9. Loré F, Nuti R, Vattimo A (1984) Vitamin D metabolites in post-menopausal osteoporosis. Horm Metab Res 16:56-57
10. Martinez ME, del Campo MT, Sanchez-Cabezudo MJ, et al. (1994) Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density. Calcif Tissue Int 55:253-256
11. Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL (1991) Interrelationship among vitamin D metabolism, true calcium-absorption, parathyroid function, and age in women: evidence of an age-related intestinal resistance to 1,25-dihydroxyvitamin D action. J Bone Miner Res 6:125-132
12. Caniggia A, Nuti R, Galli M, Loré F, Turchetti V, Righi G (1986) Effect of long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis. Calcif Tissue Int 38:328-332
13. Geusens P, Vanderschueren D, Verstraeten A, Dequeker J, Devos P, Bouillon R (1991) Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis. Calcif Tissue Int 49:168-173
14. Gallagher JC, Bishop CW, Knutson JC, Mazess RB, DeLuca H (1994) Effects of increasing doses of 1-alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 9:607-614
15. Lidor C, Sagi P, Amdr B, et al. (1993) Decrease in bone levels R. Nuti et al.: The Role of Calcitriol in the Treatment of Osteoporosis of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int 52:146-148
16. Erben RG, Bromm S, Stangassinger M (1998) Therapeutic effect of 1,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1,25-dihydroxy vitamin D3 on bone. Endocrinology 139: 4319-4328
17. Aloia JW, Vaswani A, Yeh JK, et al. (1988) Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401-408
18. Caniggia A, Nuti R, Loré F, et al. (1990) Long-term treatment with calcitriol in postmenopausal osteoporosis. Metabolism 39(Suppl) 1:43-49
19. Gallagher JC, Goldgar D (1990) Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 113:649-655
20. Ott SM, Chesnut CH III (1989) Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110:267-274
21. Jensen GF, Christiansen C, Transbol I (1982) Treatment of postmenopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxyvitamin D3 and calcium. Clin Endocrinol 16:515-524
22. Gallagher JC, Roggs BL, Recker RR (1989) The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc Soc Exp Biol 191:287-292
23. Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-6224
24. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112: 352-364.25
25. Epstein S (1996) Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:1-7
26. Gennari C, Nuti R (1993) Complications of corticosteroid therapy. In: Advances in corticosteroids. A seminar in-print. Adis Int, Langhorne, Pa, USA, pp 39-51
27. Sambrook PN, Kelly PJ, Fontana D, et al. (1994) Mechanism of rapid bone loss following cardiac transplantation. Osteoporosis Int 4:273-276
28. Sambrook PN (1996) Corticosteroid-induced osteoporosis. J Rheumatol 23:19-22
29. Dykman TR, Haralson KM, Gluck OS, et al. (1984) Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 27:1336-1343
30. Sambrook P, Birmingham J, Kelly P, et al. (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747-1752
31. Masud T, Mulcahy B, Thompson AV, et al. (1998) Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women. Ann Rheum Dis 57:346-349
32. Balhorn KE, Baynes KE, Fowler SE, Gallagher JC (1998) The effect of estrogen and calcitriol (Rocaltrol) therapy on calcium metabolism and bone markers in elderly women. J Bone Miner Res 23:S389